Study | Neonatal | Adult | ||||
---|---|---|---|---|---|---|
Health state | Utility weight | Duration | Health state | Utility weight | Duration | |
Castillo (2021) [40] | ·· | ·· | ·· | Susceptible | 1 | - |
·· | ·· | ·· | Stage 1 (primary) | 0·737 | 4·93 years | |
·· | ·· | ·· | Stage 2 (secondary) | 0·737 | 3·38 years | |
·· | ·· | ·· | Latent | 0·737 | 0·33 years | |
·· | ·· | ·· | Tertiary | 0·737 | - | |
·· | ·· | ·· | Immune | 1 | 0·2 years | |
Custer (2010) [42] | ·· | ·· | ·· | Primary syphilis | 0·88 (0·85-0·91) | 1 year |
 |  |  | Tertiary syphilis | 0·65 (0·6-0·70) | Not stated | |
Eaton (2018) [35] | ·· | ·· | ·· | Syphilis and HIV infection | 0·82 (0·69-0·93) | 1 year if positive screening test, 2 years if false negative screening test |
Hersh (2018) [36] | Congenital syphilis | 0·74 (0·6-0·8) | Lifetime | ·· | ·· | ·· |
Intrauterine fetal demise | 0 | ·· | ·· | ·· | ·· | |
Neonatal death | 0 | ·· | ·· | ·· | ·· | |
·· | ·· | ·· | Congenital syphilis (maternal perspective) | 0·88 (0·7-0·9) | Lifetime | |
·· | ·· | ·· | Stillbirth (maternal perspective) | 0·92 (0·8-0·95) | Lifetime | |
·· | ·· | ·· | Neonatal death (maternal perspective) | 0·76 (0·7-0·8) | Lifetime | |
Huntington (2020) [37] | Congenital syphilis | 0.74 | Lifetime | ·· | ·· | ·· |
Intrauterine fetal demise | 0 | ·· | ·· | ·· | ·· | |
Neonatal death | 0 | ·· | ·· | ·· | ·· | |
Suijkerbuijk (2018)a [38] | ·· | ·· | ·· | Primary syphilis | 1-0·015 = 0·985b (age 1-44 years) 1-0·014 = 0·986b (age 45+ years) | 0·04 years |
·· | ·· | ·· | Secondary syphilis | 1-0·048 = 0·952b 1-0·044 = 0·956b | 0·07 years | |
·· | ·· | ·· | Neurosyphilis | 1-0·281 = 0·719b | 10 years | |
Tuite (2014) [39] | ·· | ·· | ·· | Primary syphilis | 1-0·0072 = 0·9928b (0·0065-0·0079) | 0·7 years |
·· | ·· | ·· | Secondary syphilis | 1-0·041 = 0·959b (0·036-0·045) | 3·6 years | |
·· | ·· | ·· | Neurosyphilis and tertiary syphilis | 1-0·094 = 0·906b (0·074-0·283) | 7·7 years |